169 related articles for article (PubMed ID: 25587217)
1. Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.
Aaberg TM; Cook RW; Oelschlager K; Maetzold D; Rao PK; Mason JO
Clin Ophthalmol; 2014; 8():2449-60. PubMed ID: 25587217
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling.
Schefler AC; Skalet A; Oliver SC; Mason J; Daniels AB; Alsina KM; Plasseraud KM; Monzon FA; Firestone B
Melanoma Manag; 2020 Mar; 7(1):MMT37. PubMed ID: 32399175
[TBL] [Abstract][Full Text] [Related]
3. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
4. Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
Mruthyunjaya P; Seider MI; Stinnett S; Schefler A;
Ophthalmology; 2017 Oct; 124(10):1532-1539. PubMed ID: 28549517
[TBL] [Abstract][Full Text] [Related]
5. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications.
Correa ZM; Augsburger JJ
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):131-5. PubMed ID: 24270974
[TBL] [Abstract][Full Text] [Related]
6. Gene Expression Profiling in Uveal Melanoma: Five-Year Prospective Outcomes and Meta-Analysis.
Aaberg TM; Covington KR; Tsai T; Shildkrot Y; Plasseraud KM; Alsina KM; Oelschlager KM; Monzon FA
Ocul Oncol Pathol; 2020 Oct; 6(5):360-367. PubMed ID: 33123530
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Gene Expression Profiling and Chromosome 3 Analysis by Fluorescent in situ Hybridization and Multiplex Ligation Probe Amplification in Fine-Needle Aspiration Biopsy Specimens of Uveal Melanoma.
Klufas MA; Richter E; Itty S; Moreno C; McCannel CA; McCannel TA
Ocul Oncol Pathol; 2017 Dec; 4(1):16-20. PubMed ID: 29344493
[TBL] [Abstract][Full Text] [Related]
8. Direct Gene Expression Profile Prediction for Uveal Melanoma from Digital Cytopathology Images via Deep Learning and Salient Image Region Identification.
Liu TYA; Chen H; Gomez C; Correa ZM; Unberath M
Ophthalmol Sci; 2023 Mar; 3(1):100240. PubMed ID: 36561353
[TBL] [Abstract][Full Text] [Related]
9. Preferentially Expressed Antigen in Melanoma Immunohistochemistry Labeling in Uveal Melanomas.
Ahmadian SS; Dryden IJ; Naranjo A; Toland A; Cayrol RA; Born DE; Egbert PS; Brown RA; Mruthyunjaya P; Lin JH
Ocul Oncol Pathol; 2022 Jun; 8(2):133-140. PubMed ID: 35959159
[TBL] [Abstract][Full Text] [Related]
10. Variable Results for Uveal Melanoma-Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis.
Klufas MA; Itty S; McCannel CA; Glasgow BJ; Moreno C; McCannel TA
JAMA Ophthalmol; 2015 Sep; 133(9):1073-6. PubMed ID: 26086628
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma patient attitudes towards prognostic testing using gene expression profiling.
Williams BK; Siegel JJ; Alsina KM; Johnston L; Sisco A; LiPira K; Selig SM; Hovland PG
Melanoma Manag; 2022 Sep; 9(3):MMT62. PubMed ID: 36147875
[TBL] [Abstract][Full Text] [Related]
12. BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers.
Ida CM; Pulido J; Greipp PT; Garcia JJ; Olsen TW; Dalvin L; Salomão DR
Ocul Oncol Pathol; 2022 Feb; 8(1):22-29. PubMed ID: 35356602
[TBL] [Abstract][Full Text] [Related]
13. Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study.
Plasseraud KM; Cook RW; Tsai T; Shildkrot Y; Middlebrook B; Maetzold D; Wilkinson J; Stone J; Johnson C; Oelschlager K; Aaberg TM
J Oncol; 2016; 2016():5325762. PubMed ID: 27446211
[TBL] [Abstract][Full Text] [Related]
14. Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions.
Farberg AS; Glazer AM; White R; Rigel DS
J Drugs Dermatol; 2017 May; 16(5):428-431. PubMed ID: 28628677
[TBL] [Abstract][Full Text] [Related]
15. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
Dillon LD; McPhee M; Davidson RS; Quick AP; Martin B; Covington KR; Zolochevska O; Cook RW; Vetto JT; Jarell AD; Fleming MD
Curr Med Res Opin; 2022 Aug; 38(8):1267-1274. PubMed ID: 35081854
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Aqueous Humor Proteome Predicts Metastatic Potential in Uveal Melanoma.
Peng CC; Sirivolu S; Pike S; Kim ME; Reiser B; Li HT; Liang G; Xu L; Berry JL
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047796
[TBL] [Abstract][Full Text] [Related]
17. Improved Uveal Melanoma Copy Number Subtypes Including an Ultra-High-Risk Group.
Lalonde E; Ewens K; Richards-Yutz J; Ebrahimzedeh J; Terai M; Gonsalves CF; Sato T; Shields CL; Ganguly A
Ophthalmol Sci; 2022 Jun; 2(2):100121. PubMed ID: 36249692
[TBL] [Abstract][Full Text] [Related]
18. The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma.
Harbour JW; Chen R
PLoS Curr; 2013 Apr; 5():. PubMed ID: 23591547
[TBL] [Abstract][Full Text] [Related]
19. Small High-Risk Uveal Melanomas Have a Lower Mortality Rate.
Hussain RN; Coupland SE; Kalirai H; Taktak AFG; Eleuteri A; Damato BE; Groenewald C; Heimann H
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066842
[TBL] [Abstract][Full Text] [Related]
20. Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D.
Vichitvejpaisal P; Dalvin LA; Mazloumi M; Ewens KG; Ganguly A; Shields CL
Ophthalmology; 2019 Oct; 126(10):1445-1453. PubMed ID: 31026493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
